Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder

ClinicalTrials.gov ID: NCT02466386

Public ClinicalTrials.gov record NCT02466386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 1:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years Diagnosed With Attention-deficit / Hyperactivity Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term safety of SPD489 administered as a daily morning dose (5, 10, 15, 20, and 30 mg/day) in preschool children diagnosed with Attention-deficit/Hyperactivity Disorder (ADHD).

Study identification

NCT ID
NCT02466386
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
113 participants

Conditions and interventions

Eligibility (public fields only)

Age range
4 Years to 5 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 21, 2015 (Actual)
Primary completion
Jan 3, 2020 (Actual)
Completion
Jan 3, 2020 (Actual)
Last update posted
Mar 5, 2021

2015 – 2020

United States locations

U.S. sites
50
U.S. states
23
U.S. cities
44
Facility City State ZIP Site status
Harmonex, Inc Dothan Alabama 36303 —
Preferred Research Partners, Inc. Little Rock Arkansas 72211 —
Sun Valley Research Center Imperial California 92251 —
Alliance for Wellness d/b/a Alliance for Research Long Beach California 90807 —
AVIDA Newport Beach California 92660 —
Asclepes Research Panorama City California 91402 —
Psychiatric Centers at San Diego San Diego California 92108 —
University of California San Francisco California 94143 —
Elite Clinical Trials, Inc Wildomar California 92595 —
Avail Clinical Research, LLC DeLand Florida 32720 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Medical Research Group of Central Florida Orange City Florida 32763 —
Clinical Neuroscience Solutions Orlando Florida 32801 —
APG Research, LLC Orlando Florida 32803 —
University of South Florida St. Petersburg Florida 33701 —
University of South Florida Department Of Psychiatry Tampa Florida 33613 —
iResearch Atlanta LLC Decatur Georgia 30030 —
Lake Charles Clinical Trials Lake Charles Louisiana 70629 —
Kennedy Krieger Institute Baltimore Maryland 21205 —
Rochester Center for Behavioral Medicine Rochester Hills Michigan 48306 —
Clinical Neurophysiology Services Sterling Heights Michigan 48314 —
Washington University St Louis Missouri 63110 —
Premier Psychiatric Reseach Institute, LLC Lincoln Nebraska 68526 —
Center For Psychiatry and Behavioral Medicine In Las Vegas Nevada 89128 —
Jersey Shore University Medical Center (JSUMC) Neptune City New Jersey 7753 —
Manhattan Behavioral Medicine New York New York 10036 —
University of Rochester Rochester New York 14627 —
Duke Child and Family Center Durham North Carolina 27705 —
University of Cincinnati Cincinnati Ohio 45219 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Pediatric Associates of Fairfield, Inc. Fairfield Ohio 45014 —
IPS Research Company Oklahoma City Oklahoma 73103 —
Oklahoma Clinical Research Center Oklahoma City Oklahoma 73112 —
Paradigm Research Professionals Oklahoma City Oklahoma 73118 —
Cutting Edge Research Group Oklahoma City Oklahoma 73120 —
Cyn3rgy Research Center Gresham Oregon 97030 —
Rainbow Research Inc Barnwell South Carolina 29812 —
Carolina Clinical Trials, Inc. Charleston South Carolina 29407 —
Coastal Carolina Research Mt. Pleasant South Carolina 29464 —
Clinical Neuroscience Solutions, Inc Memphis Tennessee 38119 —
BioBehavioral Research of Austin Austin Texas 78759 —
Bayou City Research Limited Houston Texas 77007 —
BI Research Center Houston Texas 77084 —
Red Oak Psychiatry Associates Houston Texas 77090 —
Road Runner Research San Antonio Texas 78249 —
Family Psychiatry of the Woodlands The Woodlands Texas 77381 —
Ericksen Research and Development Clinton Utah 84015 —
Clinical Research Partners, LLC Petersburg Virginia 23805 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Seattle Childrens Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02466386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2021 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02466386 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →